Literature DB >> 15864413

A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem.

Avihu Boneh1,2, Stanley H Korman3, Kenichi Sato4, Junko Kanno4, Yoichi Matsubara4, Israela Lerer5, Ziva Ben-Neriah5, Shigeo Kure4.   

Abstract

Glycine encephalopathy (GE) (non-ketotic hyperglycinemia) is an autosomal recessive neurometabolic disease caused by defective activity of the glycine cleavage system. Clinically, patients present usually in the neonatal period with hypotonia, encephalopathy, hiccups and breath arrests with or without overt seizures. GE is considered rare, but its incidence is relatively high in several geographical areas around the world. We report a novel mutation causing GE in six extended Arab families, all from a small suburban village (population 5,000). A methionine to threonine change in the initiation codon of the glycine decarboxylase gene led to markedly reduced glycine decarboxylase mRNA levels and abolished glycine cleavage system activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15864413     DOI: 10.1007/s10038-005-0243-y

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  18 in total

1.  Trends in the frequencies of consanguineous marriages in the Israeli Arab community.

Authors:  L Jaber; G J Halpern; T Shohat
Journal:  Clin Genet       Date:  2000-08       Impact factor: 4.438

2.  Enzymatic diagnosis of nonketotic hyperglycinemia with lymphoblasts.

Authors:  S Kure; K Narisawa; K Tada
Journal:  J Pediatr       Date:  1992-01       Impact factor: 4.406

3.  An initiator codon mutation in ornithine-delta-aminotransferase causing gyrate atrophy of the choroid and retina.

Authors:  G A Mitchell; L C Brody; J Looney; G Steel; M Suchanek; C Dowling; V Der Kaloustian; M Kaiser-Kupfer; D Valle
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

4.  A missense mutation (His42Arg) in the T-protein gene from a large Israeli-Arab kindred with nonketotic hyperglycinemia.

Authors:  S Kure; H Mandel; M O Rolland; Y Sakata; T Shinka; A Drugan; A Boneh; K Tada; Y Matsubara; K Narisawa
Journal:  Hum Genet       Date:  1998-04       Impact factor: 4.132

5.  Incidence of inborn errors of metabolism in British Columbia, 1969-1996.

Authors:  D A Applegarth; J R Toone; R B Lowry
Journal:  Pediatrics       Date:  2000-01       Impact factor: 7.124

6.  Prognostic clues and outcome of early treatment of nonketotic hyperglycinemia.

Authors:  A Boneh; Y Degani; M Harari
Journal:  Pediatr Neurol       Date:  1996-09       Impact factor: 3.372

7.  Multiple mutations in a specific gene in a small geographic area: a common phenomenon?

Authors:  J Zlotogora; V Gieselmann; G Bach
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

8.  Molecular cloning, structural characterization and chromosomal localization of human lipoyltransferase gene.

Authors:  K Fujiwara; M Suzuki; Y Okumachi; K Okamura-Ikeda; T Fujiwara; E Takahashi; Y Motokawa
Journal:  Eur J Biochem       Date:  1999-03

9.  Phylogeographic analysis of mitochondrial DNA haplogroup F2 in China reveals T12338C in the initiation codon of the ND5 gene not to be pathogenic.

Authors:  Qing-Peng Kong; Yong-Gang Yao; Chang Sun; Chun-Ling Zhu; Li Zhong; Cheng-Ye Wang; Wang-Wei Cai; Xiang-Min Xu; An-Long Xu; Ya-Ping Zhang
Journal:  J Hum Genet       Date:  2004-07-22       Impact factor: 3.172

10.  Single base substitutions at the initiator codon in the mitochondrial acetoacetyl-CoA thiolase (ACAT1/T2) gene result in production of varying amounts of wild-type T2 polypeptide.

Authors:  Toshiyuki Fukao; Naoki Matsuo; Gai Xiu Zhang; Rintaro Urasawa; Tetsuo Kubo; Yoshinori Kohno; Naomi Kondo
Journal:  Hum Mutat       Date:  2003-06       Impact factor: 4.878

View more
  6 in total

1.  The effect of hyperglycinemic treatment in captive-bred Vervet monkeys (Chlorocebus aethiops).

Authors:  Zandisiwe E Magwebu; Mikateko Mazinu; Sahar Abdul-Rasool; Chesa G Chauke
Journal:  Metab Brain Dis       Date:  2019-06-22       Impact factor: 3.584

2.  Mutation analysis of glycine decarboxylase, aminomethyltransferase and glycine cleavage system protein-H genes in 13 unrelated families with glycine encephalopathy.

Authors:  Nor Azimah Abdul Azize; Wan Zurinah Wan Ngah; Zulhabri Othman; Norsiah Md Desa; Chen Bee Chin; Zabedah Md Yunus; Anand Mohan; Teh Siao Hean; Syed Zulkifli Syed Zakaria; Ngu Lock-Hock
Journal:  J Hum Genet       Date:  2014-09-18       Impact factor: 3.172

3.  Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: lessons learned from 10 years of clinical laboratory testing experience.

Authors:  Deeksha S Bali; Jennifer L Goldstein; Suhrad Banugaria; Jian Dai; Joanne Mackey; Catherine Rehder; Priya S Kishnani
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-01-17       Impact factor: 3.908

4.  Genomic deletion within GLDC is a major cause of non-ketotic hyperglycinaemia.

Authors:  Junko Kanno; Tim Hutchin; Fumiaki Kamada; Ayumi Narisawa; Yoko Aoki; Yoichi Matsubara; Shigeo Kure
Journal:  J Med Genet       Date:  2007-03       Impact factor: 6.318

5.  Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice.

Authors:  Yun Jin Pai; Kit-Yi Leung; Dawn Savery; Tim Hutchin; Helen Prunty; Simon Heales; Margaret E Brosnan; John T Brosnan; Andrew J Copp; Nicholas D E Greene
Journal:  Nat Commun       Date:  2015-03-04       Impact factor: 14.919

6.  The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMT.

Authors:  Curtis R Coughlin; Michael A Swanson; Kathryn Kronquist; Cécile Acquaviva; Tim Hutchin; Pilar Rodríguez-Pombo; Marja-Leena Väisänen; Elaine Spector; Geralyn Creadon-Swindell; Ana M Brás-Goldberg; Elisa Rahikkala; Jukka S Moilanen; Vincent Mahieu; Gert Matthijs; Irene Bravo-Alonso; Celia Pérez-Cerdá; Magdalena Ugarte; Christine Vianey-Saban; Gunter H Scharer; Johan L K Van Hove
Journal:  Genet Med       Date:  2016-06-30       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.